iVision Tech Toekomstige groei
Future criteriumcontroles 0/6
iVision Tech's revenue is forecast to decline at 96.7% per annum.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
| Medical Equipment winstgroei | 19.0% |
| Inkomstengroei | -96.7% |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 18 Oct 2024 |
Recente toekomstige groei-updates
Geen updates
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 25 | N/A | 2 | 3 | 1 |
| 12/31/2025 | 19 | N/A | 1 | 2 | 1 |
| 12/31/2024 | 14 | N/A | 0 | 1 | 1 |
| 12/31/2023 | 11 | N/A | -2 | 1 | 1 |
| 6/30/2023 | 10,724 | 590 | -1,757 | 577 | N/A |
| 3/31/2023 | 10,111 | 436 | -1,658 | 129 | N/A |
| 12/31/2022 | 9,497 | 282 | -1,558 | -319 | N/A |
| 12/31/2021 | 4,751 | 77 | -4,817 | -2,906 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Insufficient data to determine if IVN's forecast earnings growth is above the savings rate (2.4%).
Winst versus markt: Insufficient data to determine if IVN's earnings are forecast to grow faster than the Italian market
Hoge groeiwinsten: Insufficient data to determine if IVN's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: IVN's revenue is expected to decline over the next 3 years (-96.7% per year).
Hoge groei-inkomsten: IVN's revenue is forecast to decline over the next 3 years (-96.7% per year).
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if IVN's Return on Equity is forecast to be high in 3 years time